The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The rs641738 C>T in membrane-bound O-acyltransferase domain-containing protein 7 (MBOAT7) is implicated, along with the rs738409 C>G polymorphism in patatinlike phospholipase domain-containing protein 3 (PNPLA3), in nonalcoholic fatty liver disease (NAFLD). The association of these polymorphisms and NAFLD are investigated in Hispanic children with obesity. Methods: Obese children with and without NAFLD were enrolled at a pediatric tertiary care health system and genotyped for MBOAT7 rs641738 C>T and PNPLA3 rs738409 C>G. NAFLD was characterized by the ultrasonographic presence of hepatic steatosis along with persistently elevated liver enzymes. Genetic variants and demographic and biochemical data were analyzed for the effects on NAFLD. Results: Among 126 enrolled subjects, 84 in the case group had NAFLD and 42 in the control group did not. The two groups had similar demographic distribution. NAFLD was associated with abnormal liver enzymes and elevated triglycerides and cholesterol (p<0.05). Children with NAFLD had higher percentage of PNPLA3 GG genotype at 70.2% versus 31.0% in non- NAFLD, and lower MBOAT7 TT genotype at 4.8% versus 16.7% in non-NAFLD (p<0.05). PNPLA3 rs738409 C>G had an additive effect in NAFLD; however, MBOAT7 rs641738 C>T had no effects alone or synergistically with PNPLA3 polymorphism. NAFLD risk increased 3.7-fold in subjects carrying PNPLA3 GG genotype and decreased in MBOAT7 TT genotype. Conclusion: In Hispanic children with obesity, PNPLA3 rs738409 C>G polymorphism increased the risk for NAFLD. The role of MBOAT7 rs641738 variant in NAFLD is less evident.
Abstract
Purpose: The rs641738 C>T in membrane-bound O-acyltransferase domain-containing protein 7 (MBOAT7) is implicated, along with the rs738409 C>G polymorphism in patatinlike phospholipase domain-containing protein 3 (PNPLA3), in nonalcoholic fatty liver disease (NAFLD). The association of these polymorphisms and NAFLD are investigated in Hispanic children with obesity. Methods: Obese children with and without NAFLD were enrolled at a pediatric tertiary care health system and genotyped for MBOAT7 rs641738 C>T and PNPLA3 rs738409 C>G. NAFLD was characterized by the ultrasonographic presence of hepatic steatosis along with persistently elevated liver enzymes. Genetic variants and demographic and biochemical data were analyzed for the effects on NAFLD. Results: Among 126 enrolled subjects, 84 in the case group had NAFLD and 42 in the control group did not. The two groups had similar demographic distribution. NAFLD was associated with abnormal liver enzymes and elevated triglycerides and cholesterol (p<0.05). Children with NAFLD had higher percentage of PNPLA3 GG genotype at 70.2% versus 31.0% in non- NAFLD, and lower MBOAT7 TT genotype at 4.8% versus 16.7% in non-NAFLD (p<0.05). PNPLA3 rs738409 C>G had an additive effect in NAFLD; however, MBOAT7 rs641738 C>T had no effects alone or synergistically with PNPLA3 polymorphism. NAFLD risk increased 3.7-fold in subjects carrying PNPLA3 GG genotype and decreased in MBOAT7 TT genotype. Conclusion: In Hispanic children with obesity, PNPLA3 rs738409 C>G polymorphism increased the risk for NAFLD. The role of MBOAT7 rs641738 variant in NAFLD is less evident.
참고문헌 (37)
- Schwimmer JB, "Prevalence of fatty liver in children and adolescents", Pediatrics, 118, pp.1388~1393 (2006)
- Doycheva I, "Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States", J Clin Gastroenterol, 52, pp.339~346 (2018)
- Anderson EL, "The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis", PLoS One, 10, pp.e0140908~ (2015)
- Marzuillo P, "Pediatric fatty liver disease : role of ethnicity and genetics", World J Gastroenterol, 20, pp.7347~7355 (2014)
- Fraser A, "Prevalence of elevated alanine aminotransferase among US adolescents and associated factors : NHANES 1999-2004", Gastroenterology, 133, pp.1814~1820 (2007)
- Santoro N, "The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants", Diabetes Care, 36, pp.1353~1360 (2013)
- Utzschneider KM, "Review : the role of insulin resistance in nonalcoholic fatty liver disease", J Clin Endocrinol Metab, 91, pp.4753~4761 (2006)
- Loomba R, "Heritability of hepatic fibrosis and steatosis based on a prospective twin study", Gastroenterology, 149, pp.1784~1793 (2015)
- Tomizawa M, "Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes", Biomed Rep, 2, pp.633~636 (2014)
- Mayo R, "Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis : results from discovery and validation cohorts", Hepatol Commun, 2, pp.807~820 (2018)
- Kallwitz ER, "Ethnicity and nonalcoholic fatty liver disease in an obesity clinic : the impact of triglycerides", Dig Dis Sci, 53, pp.1358~1363 (2008)
- Ipsen DH, "Molecular mechanisms of hepatic lipid accumulation in nonalcoholic fatty liver disease", Cell Mol Life Sci, 75, pp.3313~3327 (2018)
- Buch S, "A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis", Nat Genet, 47, pp.1443~1448 (2015)
- Del Campo JA, "Genetic and epigenetic regulation in nonalcoholic fatty liver disease(NAFLD)", Int J Mol Sci, 19, pp.911~ (2018)
- Romeo S, "Genetic variation in PNPLA3confers susceptibility to nonalcoholic fatty liver disease", Nat Genet, 40, pp.1461~1465 (2008)
- Hyysalo J, "Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 27, pp.951~956 (2012)
- Hotta K, "Association of the rs738409polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease", BMC Med Genet, 11, pp.172~ (2010)
- Santoro N, "A common variant in the patatin-like phospholipase 3 gene(PNPLA3)is associated with fatty liver disease in obese children and adolescents", Hepatology, 52, pp.1281~1290 (2010)
- Lin YC, "A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children", J Pediatr, 158, pp.740~744 (2011)
- Mangge H, "Patatin-like phospholipase 3(rs738409)gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages", Aliment Pharmacol Ther, 42, pp.99~105 (2015)
- Di Sessa A, "The membrane-bound O-acyltransferase7 rs641738 variant in pediatric nonalcoholic fatty liver disease", J Pediatr Gastroenterol Nutr, 67, pp.69~74 (2018)
- Mancina RM, "The MBOAT7-TMC4variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent", Gastroenterology, 150, pp.1219~1230 (2016)
- Umano GR, "The rs626283 variant in the MBOAT7 gene is associated with insulin resistance and fatty liver in Caucasian obese youth", Am J Gastroenterol, 113, pp.376~383 (2018)
- Viitasalo A, "Association of MBOAT7 gene variant with plasma ALT levels in children : the PANIC study", Pediatr Res, 80, pp.651~655 (2016)
- Krawczyk M, "Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study", J Lipid Res, 58, pp.247~255 (2017)
- Lin YC, "Genetic determinants of hepatic steatosis and serum cytokeratin-18fragment levels in Taiwanese children", Liver Int, 38, pp.1300~1307 (2018)
- Koo BK, "Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 33, pp.1277~1285 (2018)
- Kawaguchi T, "Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers", PLoS One, 13, pp.e0185490~ (2018)
- Wattacheril J, "Genome-wide associations related to hepatic histology in nonalcoholic fatty liver disease in Hispanic boys", J Pediatr, 190, pp.100~107 (2017)
- Basyte-Bacevice V, "TM6SF2and MBOAT7 gene variants in liver fibrosis and cirrhosis", Int J Mol Sci, 20, pp.1277~ (2019)
- Sookoian S, "Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7-intergenic downstream variant-in the susceptibility to nonalcoholic fatty liver disease", Sci Rep, 8, pp.5097~ (2018)
- Di Costanzo A, "Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity", Pediatr Res, 85, pp.671~677 (2019)
- Hernaez R, "Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey", Clin Gastroenterol Hepatol, 11, pp.1183~1190 (2013)
- Tricò D, "Metabolic features of nonalcoholic fatty liver(NAFL)in obese adolescents : findings from a multiethnic cohort", Hepatology, 68, pp.1376~1390 (2018)
- Martínez LA, "The expression of PNPLA3 polymorphism could be the key for severe liver disease in NAFLD in Hispanic population", Ann Hepatol, 16, pp.909~915 (2017)
- Chinchilla-López P, "More evidence for the genetic susceptibility of Mexican population to nonalcoholic fatty liver disease through PNPLA3", Ann Hepatol, 17, pp.250~255 (2018)
- Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)